Frederick Wilhelm Thielen

Assistant professor

Erasmus Universiteit Rotterdam Erasmus School of Health Policy and Management

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Ronak Delewi

University of Amsterdam

NETHERLANDS

View details

Brenda Leeneman

Assistant professor

Erasmus Universiteit Rotterdam Erasmus School of Health Policy and Management

NETHERLANDS

View details

Hedwig Blommestein

Associate professor

Erasmus University Rotterdam

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Frederick Wilhelm Thielen

Research Interests

Explore related searches

Contact this professor

Articles (10)

Health‐related quality of life in patients with steroid‐refractory acute graft‐versus‐host disease

Cost-effectiveness of Venetoclax plus Obinutuzumab versus Chlorambucil plus Obinutuzumab for the First-Line Treatment of Adult Patients with Chronic Lymphocytic Leukemia – an extended societal view

Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma

Cost-effectiveness of lenalidomide plus rituximab versus rituximab monotherapy in patients with previously treated follicular lymphoma: a societal view

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future

Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation

Aspirin with or without clopidogrel after transcatheter aortic-valve implantation

Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country

Cost-effectiveness of Anti-CD19 chimeric antigen receptor T-Cell therapy in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. A societal view

Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis

Collaborators (3)

Ronak Delewi

Brenda Leeneman

Hedwig Blommestein

Make your next move.